GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Accumulated other comprehensive income (loss)

Fulgent Genetics (MEX:FLGT) Accumulated other comprehensive income (loss) : MXN-18 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Fulgent Genetics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was MXN-18 Mil.

Fulgent Genetics's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (MXN-294 Mil) to Dec. 2023 (MXN20 Mil) but then declined from Dec. 2023 (MXN20 Mil) to Mar. 2024 (MXN-18 Mil).

Fulgent Genetics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (MXN-16 Mil) to Dec. 2022 (MXN-408 Mil) but then increased from Dec. 2022 (MXN-408 Mil) to Dec. 2023 (MXN20 Mil).


Fulgent Genetics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Fulgent Genetics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Accumulated other comprehensive income (loss) Chart

Fulgent Genetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.75 8.71 -15.57 -407.53 20.45

Fulgent Genetics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -309.96 -355.67 -294.22 20.45 -18.29

Fulgent Genetics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Fulgent Genetics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Fulgent Genetics (MEX:FLGT) Business Description

Industry
Traded in Other Exchanges
Address
4978 Santa Anita Avenue, Temple City, CA, USA, 91780
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics (MEX:FLGT) Headlines

From GuruFocus

Fulgent Expands Board of Directors with Addition of Reggie Groves

By Business Wire Business Wire 01-03-2023

This Insider Just Sold Shares of Fulgent Genetics Inc

By GuruFocus Research GuruFocus Editor 05-20-2023